A comprehensive Business Impact Analysis (BIA) extends beyond understanding individual business processes to identifying the internal and external dependencies that enable those processes to operate.
Within Pharmaceutical Procurement and Supply Management, each Sub-Critical Business Function relies on people, business units, suppliers, logistics providers, technology partners, regulators, and healthcare institutions.
If one of these dependencies becomes unavailable, the disruption may rapidly propagate across the pharmaceutical supply chain, affecting medicine availability and ultimately patient care.
Dependency mapping provides visibility into how business functions interact throughout the organisation and across the broader healthcare ecosystem. Internal dependencies typically involve functions such as Finance, ICT, Legal, Clinical Services, Quality Assurance, Warehousing, and Enterprise Risk Management.
External dependencies include pharmaceutical manufacturers, distributors, logistics providers, cloud service providers, and government agencies. Understanding these relationships enables ALPS Healthcare to identify potential single points of failure and implement appropriate mitigation strategies.
An important aspect of dependency analysis is understanding the direction of each dependency. Upstream dependencies provide the information, approvals, resources, or services required before a Sub-Critical Business Function can be performed. Downstream dependencies consume the outputs generated by the Sub-Critical Business Function.
Mutual dependencies exist where both parties continuously rely upon each other to deliver their respective responsibilities. Analysing these relationships supports Business Continuity Planning, Third-Party Risk Management, supplier resilience, and Operational Resilience by ensuring that recovery strategies address not only internal capabilities but also critical external partners.
Table P5: Inter‑dependencies for CBF-2
|
Sub-CBF Code |
Sub-Critical Business Function |
Business Unit / Vendor / Supplier / Outsourcing Partner |
Internal Dependency |
External Dependency |
Dependency Direction |
Description of the Nature of Dependency |
|
CBF-2.1 |
Pharmaceutical Demand Forecasting |
Clinical Services & Hospital Pharmacy Departments |
Yes |
No |
Upstream |
Clinical demand forecasts, consumption trends, and treatment plans are required to produce accurate pharmaceutical forecasts. Without timely data, procurement volumes may be inaccurate. |
|
CBF-2.2 |
Pharmaceutical Requirements Planning |
Supply Chain Planning Department |
Yes |
No |
Mutual |
Procurement planning relies on inventory and demand information while downstream procurement activities depend on approved planning outputs. |
|
CBF-2.3 |
Approved Drug Catalogue Management |
Pharmacy Governance & Formulary Committee |
Yes |
No |
Upstream |
Approved medicine lists, formulary decisions, and product specifications are required before procurement activities can proceed. |
|
CBF-2.4 |
Supplier Qualification and Evaluation |
Pharmaceutical Manufacturers and Distributors |
No |
Yes |
Mutual |
Supplier qualification depends on external quality documentation, audits, and certifications, while suppliers rely on ALPS approval to participate in procurement. |
|
CBF-2.5 |
Pharmaceutical Tender and Sourcing Management |
Approved Pharmaceutical Suppliers |
No |
Yes |
Mutual |
Tender processes require supplier quotations and technical submissions. Suppliers depend on transparent tender outcomes and contract awards. |
|
CBF-2.6 |
Contract and Pricing Management |
Finance Department |
Yes |
No |
Mutual |
Finance provides budget approval and payment governance while procurement supplies contract commitments and pricing information. |
|
CBF-2.7 |
Purchase Order Processing |
Enterprise Resource Planning (ERP) Support Team |
Yes |
No |
Upstream |
Purchase order processing depends on ERP availability, master data integrity, and workflow approvals. System failures prevent order issuance. |
|
CBF-2.8 |
Regulatory and Product Compliance Verification |
National Regulatory Authority and Product Registration Databases |
No |
Yes |
Upstream |
Procurement decisions depend on valid regulatory approvals, product registrations, and compliance information before medicines can be sourced. |
|
CBF-2.9 |
Pharmaceutical Supply Scheduling |
Third-Party Logistics (3PL) Providers |
No |
Yes |
Mutual |
Delivery schedules rely on logistics provider capacity, while logistics partners require accurate shipping schedules and receiving instructions. |
|
CBF-2.10 |
Pharmaceutical Receipt and Inspection Coordination |
Central Warehouse Operations |
Yes |
No |
Mutual |
Warehouse staff perform receipt verification and inspection while procurement relies on confirmed receipt before supplier obligations are completed. |
|
CBF-2.11 |
Cold Chain and Controlled Storage Coordination |
Cold Chain Logistics Provider |
No |
Yes |
Mutual |
Temperature-controlled transport and storage require continuous coordination. Loss of cold-chain capability may compromise pharmaceutical integrity. |
|
CBF-2.12 |
Pharmaceutical Inventory Replenishment |
Warehouse Inventory Management Team |
Yes |
No |
Mutual |
Inventory replenishment depends on accurate stock information while warehouse operations rely on replenishment instructions to maintain availability. |
|
CBF-2.13 |
Drug Shortage Monitoring and Mitigation |
Pharmaceutical Manufacturers and Regional Distributors |
No |
Yes |
Upstream |
External suppliers provide shortage notifications, allocation information, and alternative sourcing options. Delays reduce mitigation opportunities. |
|
CBF-2.14 |
Supplier Performance Management |
Strategic Suppliers |
No |
Yes |
Mutual |
Supplier performance metrics depend on delivery, quality, and responsiveness data while suppliers receive performance feedback for continual improvement. |
|
CBF-2.15 |
Pharmaceutical Recall Coordination |
Pharmaceutical Manufacturers and Regulatory Authorities |
No |
Yes |
Mutual |
Recall notices originate from manufacturers or regulators, while ALPS provides product traceability, isolation, and recall execution feedback. |
|
CBF-2.16 |
Procurement Risk Monitoring |
Enterprise Risk Management (ERM) Department |
Yes |
No |
Mutual |
Procurement risk information is shared with enterprise risk management while enterprise risk assessments guide procurement mitigation activities. |
|
CBF-2.17 |
Pharmaceutical Procurement Information Management |
ICT Department |
Yes |
No |
Upstream |
Procurement records depend on secure information systems, databases, backups, and identity management services. Technology failures affect operational continuity. |
|
CBF-2.18 |
Pharmaceutical Procurement Reporting and Governance |
Executive Management |
Yes |
No |
Downstream |
Procurement reporting supports executive oversight, governance decisions, resource allocation, and strategic risk management during normal operations and disruptions. |
Mapping the inter-dependencies supporting Pharmaceutical Procurement and Supply Management enables ALPS Healthcare to understand how each Sub-Critical Business Function relies on internal business units, external suppliers, logistics providers, technology services, and governance functions.
This analysis extends the Business Impact Analysis beyond individual processes by identifying the critical relationships that sustain the uninterrupted supply of pharmaceuticals across Singapore's public healthcare system.
Understanding both internal and external dependencies improves recovery planning by highlighting where disruptions are most likely to occur and where contingency arrangements are required. Internal dependencies inform cross-functional recovery coordination, while external dependencies support supplier continuity planning, logistics resilience, contract management, and third-party risk management.
These insights enable continuity strategies to address not only ALPS Healthcare's internal capabilities but also the resilience of organisations that contribute to the end-to-end pharmaceutical supply chain.
Dependency mapping also provides valuable input into Business Continuity Plans (BCPs), supplier resilience programmes, and enterprise risk management by identifying potential single points of failure and opportunities to diversify critical resources.
During major disruptions, management can use dependency information to prioritise recovery activities, coordinate with key stakeholders, activate alternate suppliers or logistics arrangements, and restore the most critical procurement capabilities first.
Collectively, this strengthens ALPS Healthcare's operational resilience and enhances its ability to maintain the timely, safe, and compliant procurement of pharmaceuticals under adverse conditions
| eBook 3: Starting Your BCM Implementation |
||||||
| MBCO [x] | P&S [x] | RAR T1 [x] | RAR T2 [x] | RAR T3 [x] | BCS T1 [x] | CBF |
| CBF-2 Pharmaceutical Procurement and Supply Management | ||||||
| DP | BIAQ P1 | BIAQ P2 | BIAQ P3 | BIAQ P4 | BIAQ P5 | BIAQ P6 |
| BCS T2 | BCS T3 | PD | ||||
To learn more about the course and schedule, click the buttons below for the BCM-300 Business Continuity Management Implementer [BCM-3] and the BCM-5000 Business Continuity Management Expert Implementer [BCM-5].
|
Please feel free to send us a note if you have any questions. |
||